Archives: Speakers

Kiri is an internationally-recognised expert in the design of clinical trials for CNS disorders, particularly schizophrenia. As Director of Neuroscience at Cambridge Cognition, Kiri provided consultancy to over 50 drug development companies on more than 100 clinical trials and was the lead scientist on a number of successful programmes. Kiri chaired the ICSTM working group on schizophrenia clinical trials and is currently an Assistant Professor at the University of Nottingham, Department of Psychology where she is involved in on-going collaborations in schizophrenia and anxiety disorders.

Francesca is Chief Scientist at Cambridge Cognition. She has extensive experience of statistics, cognitive neuroscience and cognitive test development in a range of clinical populations. Since joining Cambridge Cognition in 2014, Francesca has worked to develop novel cognitive testing methodology to support high-frequency, near patient testing using digital technology, providing researchers and healthcare providers with unique insights into cognitive health. Francesca obtained a PhD in Dementia with Lewy Bodies at Newcastle University, followed by post-doctoral and academic positions at University College London and at the Medical Research Council in Cambridge. She maintains academic collaborations focused on neurological disorders, ageing and dementia.

Christine Guo leads the clinical and data science team at ActiGraph, responsible for the scientific strategy and services supporting ActiGraph‘s leadership in digital medicine. Christine has over 15 years of experience in clinical research and a vision for leveraging technology in clinical trials and practice. Prior to ActiGraph, Christine was Head of Scientific Innovation at Biogen Healthcare Solutions, leading the clinical development and validation of Biogen’s digital medicine products (Software as Medical device) in multiple sclerosis, neuromuscular and neurodegenerative diseases. Christine brings unique scientific insights by bridging across clinical and technical disciplines and is passionate about leveraging data and technology to improve people’s health. Christine holds a B.A. in biological sciences from Peking University and Ph.D. in neuroscience from Stanford university.

Bettina Cassegrain is the driving force behind HLB’s commitment to professional excellence and sustainable business practices. As the Global Director of Professional Standards and Sustainability Assurance, she oversees the network’s robust quality assurance programme, ensuring compliance with the stringent requirements set forth by the Forum of Firms. With a pragmatic approach to training and development, Bettina has built a culture of continuous learning within HLB. Her leadership extends to outreach initiatives focused on training, quality assurance, and related matters across Europe, Eurasia, French-speaking Africa, Latin America, and South America.

Recognising the growing importance of environmental, social, and governance (ESG) factors, Bettina has led the development of a global comprehensive ESG methodology. This framework empowers businesses to navigate the complexities of sustainability reporting and assurance. Under her guidance, HLB has developed leading-edge sustainability assurance working papers and training modules, equipping professionals with the knowledge and tools to drive positive change. Bettina’s dedication to professional standards and sustainability assurance has solidified HLB’s reputation as a global leader in delivering exceptional client services while promoting responsible business practices that create long-term value and sustainable impact for stakeholders and society at large.